Atherogenic vascular and lipid phenotypes in young patients with Type 1 diabetes are associated with diabetes high-risk HLA genotype

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 5, 2007, Pages

  Odermarsky, Michal ^a   Nilsson, Anita ^a   Lernmark, Åke ^a   Sjöblad, Sture ^a   Liuba, Petru ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Genetics; Lipids; Vascular function

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLYCERYL TRINITRATE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OROSOMUCOID;

ADOLESCENT; ADULT; ANALYSIS OF COVARIANCE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BODY MASS; BRACHIAL ARTERY; CAROTID ARTERY; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HIGH RISK POPULATION; HLA SYSTEM; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTIMA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 36148978532     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00795.2007     Document Type: Article

References (28)

1. Barker JM. Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab 91: 1210-1217, 2006.
2. Creager MA, Lüscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy. Circulation 108: 1527-1532, 2003.
3. Daneman D. Type 1 diabetes. Lancet 367: 847-858, 2006.
4. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 109: 27-32, 2004.
5. Eckel RH, Wassef M, Chait A, Sobel B, Barrett E, King G, Lopes-Virella M, Reusch J, Ruderman N, Steiner G, Vlassara H. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation 105: e138-e143, 2002.
6. Greening JE, Tree TI, Kotowicz KT, van Halteren AG, Roep BO, Klein NJ, Peakman M. Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells. Diabetes 52: 717-725, 2003.
7. Goldberg IJ, Dansky HM. Diabetic vascular disease: an experimental objective. Arterioscler Thromb Vasc Biol 26: 1693-1701, 2006.
8. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91: 281-291, 2002.
9. Jarvisalo MJ, Harmoinen A, Hakanen M, Paakkunainen U, Viikari J, Hartiala J, Lehtimäki T, Simell O, Raitakari OT. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 22: 1323-1328, 2002.
10. Jordan MS, Riley MP, von Boehmer H, Caton AJ. Anergy and suppression regulate CD4(+) T cell responses to a self peptide. Eur J Immunol 30: 136-144, 2000.
11. Joshua IG, Zhang Q, Falcone JC, Bratcher AP, Rodriguez WE, Tyagi SC. Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide. J Cell Biochem 96: 1149-1156, 2005.
12. Kershnar AK, Daniels SR, Imperatore G, Palla SL, Petitti DB, Pettitt DJ, Marcovina S, Dolan LM, Hamman RF, Liese AD, Pihoker C, Rodriguez BL. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr 149: 314-319, 2006.
13. Lernmark A. Type 1 diabetes as a model for prediction and diagnosis. Autoimmunity 37: 341-345, 2004.
14. Lernmark B, Lynch K, Lernmark A. Cord blood islet autoantibodies are related to stress in the mother during pregnancy. Ann NY Acad Sci 1079: 345-349, 2006.
15. Libby P. Inflammation in atherosclerosis. Nature 420: 868-874, 2002.
16. Liuba P, Persson J, Luoma J, Ylä-Herttuala S, Pesonen E. Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima-media. Eur Heart J 24: 515-521, 2003.
17. Marelli-Berg FM, Frasca L, Weng L, Lombardi G, Lechler RI. Antigen recognition influences transendothelial migration of CD4+ T-cells. J Immunol 162: 696-703, 1999.
18. Monaco C, Andreakos E, Kiriakidis S, Feldmann M, Paleolog E. T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases. Curr Drug Targets Inflamm Allergy 3: 35-42, 2004.
19. Nordlie MA, Wold LE, Kloner RA. Genetic contributors toward increased risk for ischemic heart disease. J Mol Cell Cardiol 39: 667-679, 2005.
20. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control, and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511, 2003.
21. Picardi A, Valorani MG, Vespasiani Gentilucci U, Manfrini S, Ciofini O, Cappa M, Guglielmi C, Pozzilli P; IMDIAB Group. Raised C-reactive protein levels in patients with recent onset type 1 diabetes. Diabetes Metab Res Rev 23: 211-214, 2007.
22. Raza J, Movahed A. Current concepts of cardiovascular disease in diabetes mellitus. Int J Cardiol 89: 123-134, 2003.
23. Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1 diabetes. Recent Prog Horm Res 56: 69-89, 2001.
24. Renard CB, Kramer F, Johansson F, Lamharzi N, Tannock LR, von Herrath MG, Chait A, Bornfeldt KE. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 114: 659-668, 2004.
25. Ross R, Aqius L. The process of atherogenesis - cellular and molecular interaction: from experimental animal models to humans. Diabetologia 35: 34-40, 1992.
26. Savage CO, Brooks CJ, Harcourt GC, Picard JK, King W, Sansom DM, Willcox N. Human vascular endothelial cells process and present autoantigen to human T-cell lines. Int Immunol 7: 471-479, 1995.
27. Todd JA. Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci USA 92: 8560-8565, 1995.
28. Tree TI, Duinkerken G, Willemen S, de Vries RR, Roep BO. HLA-DQ-regulated T-cell responses to islet cell autoantigens insulin and GAD65. Diabetes 53: 1692-1699, 2004.